Salud financiera de hoja de balance de Pharmocann Global
Salud financiera controles de criterios 3/6
Pharmocann Global has a total shareholder equity of ₪223.0K and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪2.2M and ₪2.0M respectively.
Información clave
0%
Ratio deuda-patrimonio
₪0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | ₪612.00k |
| Patrimonio | ₪223.00k |
| Total pasivo | ₪1.95m |
| Activos totales | ₪2.18m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence
Mar 30
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?
Feb 04Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 31
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come
Nov 26Análisis de la situación financiera
Pasivos a corto plazo: PMCN-M's short term assets (₪1.1M) do not cover its short term liabilities (₪1.8M).
Pasivo a largo plazo: PMCN-M's short term assets (₪1.1M) exceed its long term liabilities (₪151.0K).
Historial y análisis de deuda-patrimonio
Nivel de deuda: PMCN-M is debt free.
Reducción de la deuda: PMCN-M has no debt compared to 5 years ago when its debt to equity ratio was 0.7%.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: PMCN-M has less than a year of cash runway based on its current free cash flow.
Pronóstico de cash runway: PMCN-M has less than a year of cash runway if free cash flow continues to reduce at historical rates of 34.9% each year